Expert Opinion on Emerging Drugs, pages 1-12

Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder

Elliot Hampsey ¹

Luke Jelen ¹

Allan H. Young ^{1, 2}

Centre for Affective Disorders, King’s College London, London, UK |

South London & Maudsley NHS Foundation Trust, London, UK |

Publication type: Journal Article

Publication date: 2024-05-08

Taylor & Francis

Journal: Expert Opinion on Emerging Drugs

scimago Q1

SJR: 0.881

CiteScore: 5.9

Impact factor: 2.7

ISSN: 14728214, 17447623

DOI: 10.1080/14728214.2024.2345645

Copy DOI

Found

	1
European Archives of Psychiatry and Clinical Neuroscience	European Archives of Psychiatry and Clinical Neuroscience, 1, 25% European Archives of Psychiatry and Clinical Neuroscience 1 publication, 25%
Expert Opinion on Emerging Drugs	Expert Opinion on Emerging Drugs, 1, 25% Expert Opinion on Emerging Drugs 1 publication, 25%
Pharmaceuticals	Pharmaceuticals, 1, 25% Pharmaceuticals 1 publication, 25%
	1

	1
Springer Nature	Springer Nature, 1, 25% Springer Nature 1 publication, 25%
Taylor & Francis	Taylor & Francis, 1, 25% Taylor & Francis 1 publication, 25%
MDPI	MDPI, 1, 25% MDPI 1 publication, 25%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 25% Cold Spring Harbor Laboratory 1 publication, 25%
	1

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex

Found error?

Publisher

Taylor & Francis

Journal

scimago Q1

SJR

0.881

CiteScore

5.9

Impact factor

2.7

ISSN

14728214 (Print)

17447623 (Electronic)